Reduction in IL-33 expression exaggerates ischaemia/reperfusion-induced myocardial injury in mice with diabetes mellitus

Cardiovascular Research

Volumn 94, Issue 2, 2012, Pages 370-378

  Rui, Tao ^a,b,c,d   Zhang, Jinchao ^b,d   Xu, Xuemei ^b   Yao, Yongwei ^a,b,d   Kao, Raymond ^b,c   Martin, Claudio M ^b,c  

^a JIANGSU UNIVERSITY   (China)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d WESTERN UNIVERSITY   (Canada)

Author keywords

Diabetes mellitus; IL 33; Ischaemia reperfusion injury; PKC II

Indexed keywords

DIACYLGLYCEROL KINASE; DIACYLGLYCEROL KINASE ZETA; GLUCOSE; INTERLEUKIN 33; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOXIA; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; DOWN REGULATION; HEART; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION; UPREGULATION;

ANIMALS; APOPTOSIS; DIABETES COMPLICATIONS; DOWN-REGULATION; INTERLEUKINS; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PROTEIN KINASE C;

EID: 84860210243     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs015     Document Type: Article

References (32)

1. Winer N, Sowers JR. Epidemiology of diabetes. J Clin Pharmacol 2004;44:397-405. (Pubitemid 38396785)
2. Luscher TF, Creager MA, Beckman JA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation 2003;108:1655-1661. (Pubitemid 37187795)
3. Heather LC, Clarke K. Metabolism, hypoxia and the diabetic heart. J Mol Cell Cardiol 2011;50:598-605.
4. Yin T, Hou R, Liu S, Lau WB, Wang H, Tao L. Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury. J Mol Cell Cardiol 2010;49:354-361.
5. Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 2008;7:827-840.
6. Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010;10:103-110.
7. Seki K, Sanada S, Kudinova AY, Steinhauser ML, Handa V, Gannon J et al. Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circ Heart Fail 2009;2:684-691.
8. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 2007;117:1538-1549. (Pubitemid 46871338)
9. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107: 1058-1070.
10. Arimoto T, Takeishi Y, Takahashi H, Shishido T, Niizeki T, Koyama Y et al. Cardiacspecific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice. Circulation 2006; 113:60-66. (Pubitemid 43958489)
11. Nagareddy PR, Soliman H, Lin G, Rajput PS, Kumar U, McNeill JH et al. Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthasemediated cardiovascular abnormalities in streptozotocin-induced diabetic rats. Diabetes 2009;58:2355-2364.
12. Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 2010;106:1319-1331.
13. Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M et al. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 2004;114:1741-1751. (Pubitemid 40385530)
14. Xu H, Yao Y, Su Z, Yang Y, Kao R, Martin CM et al. Endogenous HMGB1 contributes to ischemia/reperfusion-induced myocardial apoptosis by potentiating the effect of TNF{alpha}/JNK. Am J Physiol Heart Circ Physiol 2011;300:H913-H921.
15. Zhao X, Chen YR, He G, Zhang A, Druhan LJ, Strauch AR et al. Endothelial nitric oxide synthase (NOS3) knockout decreases NOS2 induction, limiting hyperoxygenation and conferring protection in the postischemic heart. Am J Physiol Heart Circ Physiol 2007;292:H1541-H1550. (Pubitemid 46377143)
16. Xu H, Su Z, Wu J, Yang M, Penninger JM, Martin CM et al. The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway. J Immunol 2010;184:1492-1498.
17. Ichinose F, Buys ES, Neilan TG, Furutani EM, Morgan JG, Jassal DS et al. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. Circ Res 2007;100:130-139. (Pubitemid 46066781)
18. He X, Kan H, Cai L, Ma Q. Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes. J Mol Cell Cardiol 2009;46:47-58.
19. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 1992;89:11059-11063.
20. Yang M, Wu J, Martin CM, Kvietys PR, Rui T. Important role of p38 MAP kinase/NF-{kappa}B signaling pathway in the sepsis-induced conversion of cardiac myocytes to a proinflammatory phenotype. Am J Physiol Heart Circ Physiol 2008;294: H994-H1001. (Pubitemid 351253313)
21. Niizeki T, Takeishi Y, Arimoto T, Takahashi H, Shishido T, Koyama Y et al. Cardiacspecific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction. Am J Physiol Heart Circ Physiol 2007;292:H1105-H1112.
22. Kinoshita JH, Nishimura C. The involvement of aldose reductase in diabetic complications. Diabetes Metab Rev 1988;4:323-337.
23. Kaneko M, Bucciarelli L, Hwang YC, Lee L, Yan SF, Schmidt AM et al. Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury. Ann N Y Acad Sci 2005;1043:702-709. (Pubitemid 41123963)
24. Hwang YC, Sato S, Tsai JY, Yan S, Bakr S, Zhang H et al. Aldose reductase activation is a key component of myocardial response to ischemia. FASEB J 2002;16:243-245.
25. Han B, Baliga R, Huang H, Giannone PJ, Bauer JA. Decreased cardiac expression of vascular endothelial growth factor and redox imbalance in murine diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2009;297:H829-H835.
26. Westermann D, Van LS, Dhayat S, Dhayat N, Escher F, Bucker-Gartner C et al. Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy. Diabetes 2007;56:1834-1841. (Pubitemid 47025453)
27. Volz HC, Seidel C, Laohachewin D, Kaya Z, Muller OJ, Pleger ST et al. HMGB1: the missing link between diabetes mellitus and heart failure. Basic Res Cardiol 2010;105: 805-820.
28. Younce CW,Wang K, Kolattukudy PE. Hyperglycaemia-induced cardiomyocyte death is mediated via MCP-1 production and induction of a novel zinc-finger protein MCPIP. Cardiovasc Res 2010;87:665-674.
29. Kong L, Andrassy M, Chang JS, Huang C, Asai T, Szabolcs MJ et al. PKCbeta modulates ischemia-reperfusion injury in the heart. Am J Physiol Heart Circ Physiol 2008;294: H1862-H1870. (Pubitemid 351492503)
30. Hwang YC, Shaw S, Kaneko M, Redd H, Marrero MB, Ramasamy R. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury. FASEB J 2005;19:795-797. (Pubitemid 40617387)
31. Xue W, Cai L, Tan Y, Thistlethwaite P, Kang YJ, Li X et al. Cardiac-specific overexpression of HIF-1{alpha} prevents deterioration of glycolytic pathway and cardiac remodeling in streptozotocin-induced diabetic mice. Am J Pathol 2010;177:97-105.
32. Li Q, Hwang YC, Ananthakrishnan R, Oates PJ, Guberski D, Ramasamy R. Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts. Cardiovasc Diabetol 2008;7:33.